侵入性产前诊断中染色体微阵列分析的接受度:多少患者选择跨越
该研究回顾性分析某大型学术机构4年内946例侵入性产前诊断(259例绒毛取样、687例羊膜腔穿刺),整体32%选择染色体微阵列分析(CMA),接受度随时间显著上升;超声发现结构异常者最可能选择CMA,医疗补助/CHIP保险者较私人保险者更可能选择(OR=1.59)。
要点
- 4年内946例侵入性产前诊断中32%选择CMA,接受度随时间显著上升。
- 医疗补助/CHIP保险者较私人保险者更可能选择CMA(OR=1.59,95%CI 1.18-2.14)。
- 超声结构异常者最可能选择CMA,多系统异常OR=3.75,单系统异常OR=3.22。
核心结论
- 4年内某大型学术机构CMA接受度显著上升,超声指征尤其结构异常者最可能选择CMA。
研究设计与样本
- 回顾性数据库分析,纳入4年内接受绒毛取样或羊膜腔穿刺的孕妇共946例(绒毛取样259例、羊膜腔穿刺687例)。
主要发现
- 整体32%选择CMA,接受度随时间显著上升。
- 医疗补助/CHIP保险者较私人保险者更可能选择CMA(OR=1.59,95%CI 1.18-2.14)。
- 经产妇较初产妇更少选择CMA(P=0.003)。
- 超声发现者较其他任何指征更可能选择CMA。
- 多系统结构异常者(OR=3.75,95%CI 1.60-8.79)或单系统异常者(OR=3.22,95%CI 1.47-7.05)较其他类型超声发现更可能选择CMA。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Characterize the uptake of chromosomal microarray analysis (CMA) among women undergoing invasive prenatal diagnosis at a large academic institution over a 4-year time period. METHODS: Retrospective database review of women who underwent invasive prenatal diagnosis via chorionic villus sampling (CVS) or amniocentesis. Entries were reviewed for demographic and clinical information. RESULTS: Nine hundred forty-six diagnostic procedures were performed at our institution over a 4-year time period including 259 CVS and 687 amniocentesis procedures. Overall, 32% elected CMA, with a significant increase in uptake over time. Women with Medicaid/CHIP insurance were more likely to elect CMA than those with private insurance (OR = 1.59, 95% CI, 1.18-2.14), while multigravida women were less likely than primigravidas to elect CMA (P = 0.003). Women with ultrasound findings were more likely to elect CMA than any other indication. Those with structural abnormalities in multiple systems (OR = 3.75, 95% CI, 1.60-8.79) or abnormalities in a single system (OR = 3.22, 95% CI, 1.47-7.05) were more likely to elect CMA than with any other types of ultrasound findings. CONCLUSION: The uptake of CMA significantly increased over a 4-year period at a large academic institution. Women with ultrasound indications, specifically structural abnormalities, are the most likely to elect CMA.
引用
- Singletary CN, Krstic NC, Czerwinski JL, et al. Prenatal chromosomal microarray uptake with invasive prenatal diagnosis: How many patients take the leap? Prenat Diagn. 2018. PMID: 29966046. doi:10.1002/pd.5324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。